NCT05574777 - Endoscopic Gastric Mucosal Ablation (GMA) of Class III Obesity | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 13, 2023

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions

AdiposityMorbidObesity

Interventions

DEVICE

Hybrid Argonplasma coagulation (HAPC)

Gastric mucosal ablation is an endoscopic procedure which uses argonplasma coagulation in combination with submucosal injection to achieve selective ablation to the gastric mucosa and preventing thermal damage to the muscle layer.

Trial Locations (1)

Unknown

Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo